The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids

BACKGROUND: Nab-paclitaxel has been widely used in treating breast cancer and pancreatic patients for its low toxicity and high efficiency. However, its role in gastric cancer (GC) remains ambiguous. The aim of our study was to test the anti-tumor activity of nab-paclitaxel using GC patient-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xing, Chen, Wei, Wei, Zhe-Wei, Chu, Wei-Wei, Lu, Xiao-Fang, Li, Bo, Chen, Hong, Meng, Si-Jun, Hao, Teng-Fei, Wei, Ji-Tao, He, Yu-Long, Zhang, Chang-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322144/
https://www.ncbi.nlm.nih.gov/pubmed/32612367
http://dx.doi.org/10.2147/OTT.S237431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322144/
https://www.ncbi.nlm.nih.gov/pubmed/32612367
http://dx.doi.org/10.2147/OTT.S237431

Ejemplares similares